Targeting Negative Flashforward Imagery Using EMDR in Children and Adolescents with Social Anxiety Disorder: a Randomized Controlled Trial

Conditions: Social anxiety disorder (SAD)

Registration Number: NL-OMON24410

Lead Sponsor: niversity of Groningen

Brief Summary: /A

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 50

Inclusion Criteria

•Aged between 10-18 years old
•Sufficient knowledge of and proficiency in the Dutch language
•Meeting the DSM 5 criteria of social anxiety disorder, and social anxiety disorder is the current focus of care (also in case of comorbidity, such as comorbid other anxiety disorders, ASD, AD(H)D, and depression)
•Currently not receiving active treatment for social anxiety disorder (e.g., after diagnostic process or when on the waitlist for active treatment). Note that previous cognitive behavioral therapy (CBT) or other previous treatments such as EMDR are no exclusion criteria, nor is continuation of medication with a stable dosage.

Exclusion Criteria

•Absence of permission of legal guardian(s) for youths aged 10-15 years
•Serious concerns that warrant current attention such as suicidality, psychosis or domestic violence
•Comorbid post-traumatic stress disorder (PTSD) or partial PTSD after exposure to DSM 5 criterion A traumatic event(s)
•Not reporting to experience FF imagery during the pre-intervention assessment (i.e., exclusion from participation in the rest of the treatment study)
•A medical condition that is considered a contra-indication for EMDR with eye movements such as a form of epilepsy

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
- Primary outcome variables:<br>- Social anxiety and avoidance related to youths’ most feared social situations (ratings of social anxiety and avoidance related to their top 3 selected situations, based on the list of situations from the Liebowitz Social Anxiety Scale for Children and Adolescents (LSAS-CA))

Secondary Outcome Measures